8fbd035081bd09934004bfc61d79c31c5d5d9ee4

Daily Archive: April 1, 2024

Takeda, Renibus Therapeutics and more

New hires:

Deerfield Agency, a 2023 MM+M Agency 100 honoree, hired Bill Veltre as EVP, head of media.

A2 Bio named James Robinson as CEO and a member of the board of directors.

Noetik appointed Dr. Shafique Virani as chief business officer.

Clinical-stage biopharma IDRx named David P. Kerstein, MD as chief medical officer.

Poseida Therapeutics added Dr. Syed Rizvi as chief medical officer.

Healthcare marketing agency The Considered added three VPs to its leadership team.

Laverock Therapeutics appointed Ali Elsley as its finance director.

Executive elevations:

Former Medtronic PR lead Julia Fuller was promoted to MP at Ford Hutman Media. 

Healthcare amenities company HHP promoted Meg Finn to VP of marketing.

Renibus Therapeutics named co-founder and former co-CEO Jeffrey Keyser, RPh, JD, PhD as President and CEO.

Communications agency MMC announced a series of new hires and executive promotions.

Peregrine Market Access announced three promotions.

Board appointments:

Takeda Pharmaceuticals announced that Milano Furuta, who is succeeding CFO Constantine Saroukos on April 1, will be a candidate for board director at the ordinary general meeting of shareholders. If approved by shareholders,Furuta will join the board effective June 26.

Former BioMarin CEO Jean-Jacques Bienaimé was appointed chairman of the board at Owkin.

Sosei Group Corporation announced the re-election of its board of directors and executive officers at its annual shareholders meeting. The company also changed its name to Nxera Pharma.

Biopharma Chimerix named Marc Kozin to its board of directors.

Tvardi Therapeutics appointed Sujal Shah as chairman and added Shaheen Wirk to its board of directors.

Curative Biotechnology nominated Dr. Theresa Heah to its board of directors.

Biotech Psilera named Magali Haas, MD, PhD to its board of directors.

Theratechnologies added Jordan Zwick to its board of directors.

Departures:

Synthego Corporation announced that Paul Dabrowski would step

Read the rest